Making Virus Inactivation a Reality for Continuous Upscaled Processes
The Cadence™ Virus Inactivation (VI) system, a fully automated low pH virus inactivation system for both batch and continuous processing is one of the latest additions to Pall’s Continuous platform. This webinar will discuss how traditional low pH virus inactivation has been translated into an automatic system, and also the additional challenges associated with making it a continuous process. There will be a review of the two methods used for validating the design and an overview of the integration of capture chromatography and virus inactivation, which represents the first commercial scale combined unit operations in this space.

Moderator


David Johnson
Senior Global Product Manager, Continuous Purification
Pall Biotech

Speakers


Mark Schofield, Ph.D.
Principal R&D Engineer
Pall Biotech
Making Virus Inactivation a Reality for Continuous Upscaled Processes

Download our eBook on Virus Safety
Biotech | Pall Corporation webinar series
¡Todo sobre los ensayos de validaciones para cumplir con los máximos estándares regulatorios!
Hablaremos sobre puntos cruciales de los servicios de validación, incluyendo:
1. Necesidad de validación
2. Cómo se realizan los ensayos de validación
3. Análisis de riesgo: re uso de filtros y toma de decisión en ensayos a realizar
4. Servicio de Validación Pall: documentación requerida para iniciar una cotización
¡No pierdas esta segunda oportunidad!